ALXO (STOCKS)
ALX Oncology Holdings Inc. Common Stock
$1.750000
+0.050000 (+2.94%)
Prev close: $1.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jason Lettmann
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $230.31M
- Employees
- 49
- P/E (TTM)
- -0.90
- P/B (TTM)
- 3.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $104.02M |
| Depreciation and Amortization | $700.00K |
| Research and Development | $77.00M |
| Other Operating Expenses | $26.33M |
| Operating Income/Loss | -$104.02M |
| Income/Loss From Continuing Operations After Tax | -$101.70M |
| Income/Loss From Continuing Operations Before Tax | -$101.70M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Expense, Operating | $1.60M |
| Net Income/Loss | -$101.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$101.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$101.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.90 |
| Diluted Earnings Per Share | -$1.90 |
| Basic Average Shares | 53,658,399 |
| Diluted Average Shares | 53,658,399 |
| Assets | $59.05M |
| Current Assets | $50.73M |
| Prepaid Expenses | $1.07M |
| Other Current Assets | $49.66M |
| Noncurrent Assets | $8.32M |
| Fixed Assets | $1.20M |
| Other Non-current Assets | $7.12M |
| Liabilities | $33.07M |
| Current Liabilities | $24.55M |
| Accounts Payable | $4.91M |
| Wages | $4.36M |
| Other Current Liabilities | $15.28M |
| Noncurrent Liabilities | $8.51M |
| Long-term Debt | $10.17M |
| Equity | $25.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $25.98M |
| Liabilities And Equity | $59.05M |
| Net Cash Flow From Operating Activities | -$84.14M |
| Net Cash Flow From Operating Activities, Continuing | -$84.14M |
| Net Cash Flow From Investing Activities | $82.59M |
| Net Cash Flow From Investing Activities, Continuing | $82.59M |
| Net Cash Flow From Financing Activities | $362.00K |
| Net Cash Flow From Financing Activities, Continuing | $362.00K |
| Net Cash Flow | -$1.19M |
| Net Cash Flow, Continuing | -$1.19M |
| Comprehensive Income/Loss | -$101.94M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$101.94M |
| Other Comprehensive Income/Loss | -$247.00K |